Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72580 result(s) found, displaying 25301 to 25325

ESCITALUPIN escitalopram (as oxalate) 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ESCITALUPIN escitalopram (as oxalate) 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
Evertone Pty Ltd - Behind-the-ear air-conduction hearing aid Cancelled under Section 41GL(d) of the Act

24 June 2022

Cancellation by sponsor

Requested by Evertone Pty Ltd
Evertone Pty Ltd - Behind-the-ear air-conduction hearing aid Cancelled under Section 41GL(d) of the Act

24 June 2022

Cancellation by sponsor

Requested by Evertone Pty Ltd
Evertone Pty Ltd - Evertone Audiometer - Audiometer, pure-tone Cancelled under Section 41GL(d) of the Act

24 June 2022

Cancellation by sponsor

Requested by Evertone Pty Ltd
Evertone Pty Ltd - Hearing aid, in-the-ear Cancelled under Section 41GL(d) of the Act

24 June 2022

Cancellation by sponsor

Requested by Evertone Pty Ltd
EVERYDAY LUXURIES Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Mecca Brands Pty Ltd
EXTRA STRENGTH CONTAC* COMPLETE COUGH, COLD & FLU Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Haleon Australia Pty Ltd
FAMCICLOVIR FBM famciclovir 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR GENERICHEALTH famciclovir 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR GENERICHEALTH famciclovir 125 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR GENERICHEALTH famciclovir 250 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR GENERICHEALTH famciclovir 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR GENERICHEALTH famciclovir 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR GENERICHEALTH famciclovir 500 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR SCP famciclovir 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR SCP famciclovir 125 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR SCP famciclovir 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMCICLOVIR SCP famciclovir 500 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMLO famciclovir 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMLO famciclovir 125 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMLO famciclovir 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
FAMLO famciclovir 500 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
Faulding Cold + Flu Defence Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Endeavour CH Pty Ltd
Faulding Cold Sore Relief Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Endeavour CH Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

ESCITALUPIN escitalopram (as oxalate) 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ESCITALUPIN escitalopram (as oxalate) 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

Evertone Pty Ltd - Behind-the-ear air-conduction hearing aid Cancelled under Section 41GL(d) of the Act

Evertone Pty Ltd - Behind-the-ear air-conduction hearing aid Cancelled under Section 41GL(d) of the Act

Evertone Pty Ltd - Evertone Audiometer - Audiometer, pure-tone Cancelled under Section 41GL(d) of the Act

Evertone Pty Ltd - Hearing aid, in-the-ear Cancelled under Section 41GL(d) of the Act

EVERYDAY LUXURIES Cancelled under Section 30(1)(c) of the Act

EXTRA STRENGTH CONTAC* COMPLETE COUGH, COLD & FLU Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR FBM famciclovir 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR GENERICHEALTH famciclovir 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR GENERICHEALTH famciclovir 125 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR GENERICHEALTH famciclovir 250 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR GENERICHEALTH famciclovir 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR GENERICHEALTH famciclovir 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR GENERICHEALTH famciclovir 500 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR SCP famciclovir 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR SCP famciclovir 125 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR SCP famciclovir 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMCICLOVIR SCP famciclovir 500 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMLO famciclovir 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

FAMLO famciclovir 125 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMLO famciclovir 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

FAMLO famciclovir 500 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

Faulding Cold + Flu Defence Cancelled under Section 30(1)(c) of the Act

Faulding Cold Sore Relief Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?